ArticleScience advances2026

Rejuvenating endogenous antitumor immunity via a chimeric receptor-engineered oncolytic virus targeting tumor-associated macrophages.

Chaolong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.